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SUMMARY
After a peripheral nerve lesion, distal ends of injured
axons disintegrate into small fragments that are sub-
sequently cleared by Schwann cells and later by
macrophages. Axonal debris clearing is an early
step of the repair process that facilitates regenera-
tion. We show here that Schwann cells promote
distal cut axon disintegration for timely clearing. By
combining cell-based and in vivo models of nerve
lesion with mouse genetics, we show that this mech-
anism is induced by distal cut axons, which signal to
Schwann cells through PlGFmediating the activation
and upregulation of VEGFR1 in Schwann cells. In
turn, VEGFR1 activates Pak1, leading to the forma-
tion of constricting actomyosin spheres along un-
fragmented distal cut axons to mediate their disinte-
gration. Interestingly, oligodendrocytes can acquire
a similar behavior as Schwann cells by enforced
expression of VEGFR1. These results thus identify
controllable molecular cues of a neuron-glia cross-
talk essential for timely clearing of damaged axons.
INTRODUCTION
Although neurons in the peripheral nervous system (PNS) can
regenerate after lesion, regeneration in the central nervous sys-
tem (CNS) is mostly inefﬁcient (Brosius Lutz and Barres, 2014;
Jessen andMirsky, 2016). This is due largely to the different types
of glial cells present in these two systems: axonal regrowth is pro-
moted by Schwann cells (SCs) in the PNS but is inhibited by
oligodendrocytes (OLs) and the formation of a glial scar in the
CNS (Brosius Lutz and Barres, 2014). Indeed, after lesion, SCs
actively demyelinate and convert into repair cells that stimulate
axonal regrowth and later remyelinate regenerated axons (Jes-
sen and Mirsky, 2016; Cattin and Lloyd, 2016). In contrast, OLs
remain inactive or die after a CNS lesion, and their myelin that
contains growth inhibitory factors prevents axonal regrowth
(Brosius Lutz and Barres, 2014). In addition, peripheral and cen-
tral neurons have different intrinsic regenerative properties. After
a PNS lesion, peripheral neurons activate a regeneration program
by upregulating a set of genes designated as regeneration-
associated genes (RAGs). Some of these RAGs can promote
neurite outgrowth and potentially also axonal regrowth (reviewed
in Huebner and Strittmatter, 2009). In comparison, central axons
upregulate RAGs to a lower extent, indicating lower intrinsic
capacity of regeneration (Huebner and Strittmatter, 2009).
Degeneration of injured axons also occurs faster in the PNS
than in the CNS. Distal ends of injured axons separated from
the neuron soma (distal cut axons) degenerate rapidly in the
PNS after lesion (Wong et al., 2017; Vargas and Barres,
2007): within 2 days following a PNS lesion, virtually all axons
distal to the lesion site have disintegrated into small fragments
(Beirowski et al., 2005). This allows fast clearing of distal cut
axons and creates, together with demyelination, a favorable
environment for axonal regrowth (Wong et al., 2017; Vargas
and Barres, 2007). Indeed, persistent axon fragments directly
repel regenerating axon branches (Martin et al., 2010), and
delayed axonal degeneration in Wlds mutant mice leads to de-
layed axonal regrowth (Brown et al., 1992; Chen and Bisby,
1993) in the PNS. In the CNS, degeneration of distal cut axons
also occurs after spinal cord injury or stroke lesions, but this
process is a lot slower than in the PNS: although a fraction of
injured axons exhibiting an early rise of [Ca2+]i disintegrate
rapidly distal to the lesion site, a large fraction of distal cut
axons remain for a longer time (Williams et al., 2014), up to
14 days post-lesion (dpl) in the spinal cord (Buss et al.,
2005). Importantly, delaying the disintegration of distal cut
axons in the CNS reduces the extent of axonal sprouting and
thereby the potential for spontaneous axonal regeneration
(Collyer et al., 2014). Understanding the mechanisms that con-
trol axonal disintegration after lesion may make it possible to
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accelerate this process, which could have a positive impact on
PNS and CNS regeneration.
Because degeneration of distal cut axons occurs rapidly after
lesion in the PNS, we asked in this study whether SCs inﬂuence
the disintegration of distal cut axons after lesion. SCs can pro-
mote the regeneration of both PNS and CNS axons (Bunge,
2016), thus elucidating themechanisms that control SC behavior
after lesion could uncover strategies to induce SC-like behavior
in OLs and thereby stimulate CNS plasticity after lesion. To visu-
alize SC behavior after lesion, identify SCs’ underlying mecha-
nisms, and test the potential to induce SC-like behavior in OLs,
we established models of nervous system lesion in microﬂuidic
devices with co-cultures of dorsal root ganglia (DRG) neurons
and either SCs or OLs. We show that these models recapitulate
the PNS regeneration process with similar timing as in vivo and
CNS regeneration failure. By using these models, we identiﬁed
the activation by distal cut axons of a VEGFR1-Pak1 pathway
in SCs, which induces the formation of constricting actomyosin
spheres leading to SC-mediated breakdown of distal cut axons.
Indeed, in vivo-speciﬁc inactivation of VEGFR1 or SC-speciﬁc
ablation of Flt1 (Vegfr1) after lesion leads to a decrease of axonal
breakdown mediated by SCs in the distal part of the injured
nerve. In addition, we show that OLs can acquire a similar
behavior by enforced expression of VEGFR1.
RESULTS
In Vitro Lesion Models Recapitulate PNS and CNS
Distinct Regeneration Capacities
In this study, we investigated early SC plasticity mechanisms
and tested whether these mechanisms can be used to increase
OL plasticity after lesion. For this purpose, we ﬁrst established
lesion models in microﬂuidic devices constituted of two cham-
bers connected by microgrooves, in which we cultured primary
DRG neurons with SCs (Br€ugger et al., 2015) or OLs (Chen
et al., 2007). To obtain neuron/SC cultures, dissociated DRG ex-
plants are plated in chamber 1, in which neuronal cell bodies
remain because of their large diameter, but their axons grow
through microgrooves and invade chamber 2 (Figures 1A and
1B). SCs migrate to interact with and myelinate axons in the mi-
crogrooves and chambers (Figures 1A and 1C). This myelinated
co-culture system displays high density of myelination with 147
± 27 (n = 3) internodes per square millimeter in chamber 2 (Fig-
ure 1C). To obtain neuron/OL cultures, we ﬁrst purify DRG neu-
rons and then add primary OLs in chamber 2, which interact
with andmyelinate axons inmicrogrooves and in chamber 2 (Fig-
ures 1B and 1D). For live-cell imaging, we label neurons with
DsRed and SCs or OLs with GFP (Figures 1A, 1B, and 1E). In
the neuron/SC model, microgrooves are ﬁlled with SCs (Fig-
ure 1F, red asterisksmarking SC nuclei). To follow one-to-one re-
lationships between axons and SCs, we use a small amount of
GFP-expressing lentiviruses. We then carry out axonal lesions
by laser axotomy in microgrooves.
We show that the neuron/SC model recapitulates the main
steps of the PNS regeneration process, while the neuron/OL
model displays regeneration failure similar toCNS lesions (Figures
2A–2C). In the neuron/SC model, axons have degenerated and
SCs have changed their morphology at 1 dpl (Figure 2A). Although
SCs remain present in the chamber as shown by bright-ﬁeld im-
ages, myelin basic protein (MBP) signal is discontinued at 1 dpl
and absent at 5 dpl (Figure 2B), suggesting that SCs undergo
demyelination. Indeed, bright-ﬁeld images show degenerated
myelin (open pink arrowheads) at 1 dpl and absence of myelin
at 5 dpl (Figure 2B). Next, SCs extend a long process contacting
axon growth cones to guide axonal regrowth (Figure 2A; Video
S1). When axons have regrown, SCs re-interact with and remye-
linate regenerated axons (Figures 2A and 2B), as indicated by the
reformation of myelin internodes at 30 dpl (MBP staining in Fig-
ure 2B), exhibiting the typical shape of SC internodes (Figure 2B,
magniﬁcation of region highlighted by white box).
SCs do not undergo major apoptosis or proliferation after
lesion in our model (Figure S1A) but dedifferentiate, as shown
by the upregulation of the major inducer of SC dedifferentiation,
cJun (Figure S1B). In vivo, SC proliferation that occurs after
lesion but is not required for regeneration (Yang et al., 2008)
may be induced by macrophages (Stratton and Shah, 2016),
which are absent from these models. In contrast, OLs remain
apparently inactive (Figure 2C; Video S2A) or die (Figure 2C;
Videos S2B–S2D; Figure S1C) after lesion in the neuron/OL
model, and OLs continue to express myelin proteins, as shown
by the MBP signal surrounding distal cut axons until at least
15 dpl (Figure 2B). Although neurons alone regrow approxi-
mately to a similar extend after lesion when cultured in SC or
OL culture media (Figure S2), the presence of SCs increases
axonal regrowth extent after lesion, whereas axonal regrowth
is impaired in the presence of OLs in our models (Figure S2).
SCs Promote Distal Cut Axon Disintegration
Interestingly, whereas the majority of distal cut axons are disin-
tegrated (Video S3 illustrates axonal disintegration) at 1 dpl in
the neuron/SC model (Figures 2B, 3A, and 3B), distal cut axons
persist for several days when neurons are cultured alone or in the
presence of OLs (Figures 2B, 2C, and 3A–3C; Figure S2), indi-
cating that SCs accelerate distal cut axon disintegration after
lesion. In addition, we show that there is a large number of
individual axonal fragments at 12 h post-lesion (hpl) and 1 dpl
in microgrooves of neuron + SC cultures (Figures 3A and 3D)
and that the large majority of these fragments are of very small
size (Figures 3A and 3E). In contrast, there is a small number of
individual axonal fragments in neurons only and neuron + OL
cultures (Figures 3A and 3D), and a large part of these fragments
are long unfragmented distal cut axons (Figures 3A and 3E).
Taken together, these results indicate that SCs accelerate the
fragmentation of long distal cut axons into small debris.
Three-dimensional (3D) live-cell imaging analysis of GFP-
labeled SCs and DsRed-labeled axons after lesion shows that
axonal fragmentation is associated with motility of SCs around
distal cut axons (Figure 3F; Video S4). Thus, we hypothesized
that actin dynamics is involved in axonal fragmentationmediated
by SCs. Indeed, we show in our models (Figures 4A–4F; Video
S5) and in mouse sciatic nerves (Figure 4G) that after lesion,
but not before (Figures S3A and S3B), SCs form strings of actin
spheres around distal cut axons. We found that a large majority
of actin spheres surround unfragmented distal cut axons at 6 hpl
(Figure 4A, white arrows and graph), a time point when most
distal cut axons remain unfragmented. This demonstrates that
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actin spheres are formed around axons before axonal fragmen-
tation and disintegration. After lesion, SCs can also form a fun-
nel-shaped actin structure, which has been described to be
necessary for the formation and elongation of myelin ovoids
(Jung et al., 2011). Myelin ovoids were also suggested to induce
axonal fragmentation (Catenaccio et al., 2017). We show here
that although funnel-shaped actin does co-localize with degen-
erated myelin (Figure 4B, pink arrows), actin spheres do not
co-localize with these structures (Figure 4B, white arrows), indi-
cating that actin spheres formed by SCs upon lesion are distinct
from funnel-shaped actin found at myelin ovoids. Interestingly,
we observed a change in the morphology of axons surrounded
by actin spheres: axon diameter progressively expanded within
the spheres (Figure 4C, white arrowheads, and Figure 4D, white
arrows) and simultaneously shrunk at the contact points with
actin (Figures 4A and 4D, blue arrows), suggesting that actin
spheres mediate mechanical constriction-expansion of distal
cut axons. Indeed, by live-cell imaging of F-actin dynamics in
SCs using LifeAct-GFP (Riedl et al., 2008; Figure S3C) and of
DsRed-labeled axons, we conﬁrm that actin spheres constrict
distal cut axons at their contact points (Figure 4E, blue arrows)
and lead to the expansion of the portions of axon surrounded
by actin spheres (Figure 4E, white arrows) until axonal disintegra-
tion, either in non-myelinating SCs (Figure S3D) or myelinating
SCs (Figure S3E). Of note, other SCs, which are not labeled
with LifeAct-GFP, are present in microgrooves (Figure 4E, red
asterisks) and contribute to the disintegration of distal cut axons
together with LifeAct-GFP-labeled SCs. Consistent with live-cell
imaging analysis, we found a higher percentage of actin spheres
that surrounded axonal debris at 12 hpl comparedwith 6 hpl (Fig-
ure 4A, blue arrowheads and graph). Commonly, circular actin
structures that exert contractile functions are composed of actin
ﬁlaments andmyosinmotors (Schwayer et al., 2016). Indeed, our
data suggest that lesion-induced constricting actin spheres in
SCs are also composed of myosin heavy chain 1 (Figure 4F, ar-
rows), a myosin subtype mostly present in skeletal muscle, but
which has also been described in other tissues (https://www.
genecards.org). Interestingly, we also detected the formation
Figure 1. Neuron/SC and Neuron/OL Culture Models in Microﬂuidic Chambers
(A and B) Schematic representations of dual-color models of DRG neuronsmyelinated by SCs (A) or OLs (B) and live-cell imaging of chamber 2 andmicrogrooves
showing the distribution of DsRed-labeled axons and GFP-labeled SCs (A) or OLs (B). Large images are wide-ﬁeld mosaic images. Smaller images show different
3D surface-rendering views of regions highlighted by a blue box on the left image (z series projection). White scale bars, 25 mm; black scale bars, 250 mm.
(C and D) Co-immunoﬂuorescence of neuroﬁlament (NF) and myelin basic protein (MBP) in chamber 2 showing myelinated axons by SCs (C) or OLs (D). Large
images show the single-optical section displaying the highest signal intensity. Smaller images show two different 3D surface-rendering views of the region
highlighted by a blue box on the left images (z series projection). White scale bars, 25 mm; black scale bars, 250 mm.
(E) Co-immunoﬂuorescence of NF and MBP, GFP ﬂuorescence and DAPI (nuclei) labeling in GFP-labeled myelinating SC. Three-dimensional surface-rendering
views of the region highlighted by the dashed box on the upper image shows close apposition of GFP and MBP surface rendering. Representative images of
multiple cells are shown. Scale bar, 10 mm.
(F) Bright-ﬁeld pictures of three microgrooves of neuron/SC cultures. Red asterisks on the lower pictures indicate SC nuclei. Scale bar, 25 mm.
Representative images of three different chambers for each type of culture (neuron/SC and neuron/OL) are shown.
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of strings of actin spheres in mouse sciatic nerves at 1 day post-
sciatic nerve crush lesion (dpsnl) (Figure 4G, white arrows),
which surrounded constricted-expanded axons (Figure 4G,
blue arrowheads).
Taken together, these data show that after axonal lesion, SCs
form strings of constricting actomyosin spheres along unfrag-
mented distal cut axons, which correlates with the consecutive
breakdown of distal cut axons into small fragments.
Distal Cut Axons Upregulate PlGF to Activate VEGFR1-
Dependent Actin Dynamics
To identify themechanism by which SCs form actin spheres after
lesion, we started by analyzing gene regulation in SCs after
lesion. We used chamber 2, which contains mainly SC RNA (Fig-
ure S1D), for gene expression analyses at 1 dpl compared
with unlesioned conditions. Actin polymerization is initiated by
the Arp2/3 complex, which is activated by effectors that are acti-
vated byRhoGTPases (Arnold et al., 2017), themselves activated
by guanine nucleotide exchange factors (GEFs). GEF activity can
be triggered through phosphatidylinositol-3 kinase (PI3K), phos-
phatidylinositol trisphosphate (PtdIns[3,4,5]P3), and phospholi-
pase C (PLC) (Swanson, 2008). PI3K and PLC are activated by
tyrosine kinase receptors. The only tyrosine kinase receptor
that we found upregulated in our RNA sequencing (RNA-seq)
was Vegfr1 (Flt1), while the related receptors Vegfr2 (Flk1 or
Kdr) and Nrp1 were downregulated (Table S1, Tab A). We thus
hypothesized that VEGFR1 induces actin dynamics in SCs
after lesion. Other genes involved in actin-myosin dynamics
were also regulated (Table S1, Tab A). In addition to genes
involved in actin dynamics, Gene Ontology analysis revealed
regulation of other genes involved in metabolism, transport,
development, differentiation and myelination, proliferation, im-
mune reaction and chemokine production, extracellular matrix
assembly and adhesion, cell-cell interaction, migration and guid-
ance, apoptosis, and cell death and survival (Table S1, Tab B).
Regulation of these different biological functions illustrates the
well-known plastic behavior of SCs after lesion (Brosius Lutz
and Barres, 2014; Jessen and Mirsky, 2016).
Figure 2. Lesion Models Recapitulate In Vivo PNS Regeneration Process and CNS Regeneration Failure
(A) Live-cell imaging (wide-ﬁeld) of a DsRed-labeled axonmyelinated by a GFP-labeled SC (among non-labeled axons and SCs) in microgroove before lesion and
at different time points after lesion, showing the main steps of the PNS regeneration process. The dashed box shows the same GFP-labeled SC that was imaged
at different time points after lesion. See also Video S1.
(B) Co-immunoﬂuorescence of neuroﬁlament (NF) and MBP in neuron/SC and neuron/OL models in unlesioned conditions (no lesion) or at different time points
after lesion. Blue arrowheads show remaining distal cut axons after lesion. Bright-ﬁeld images in neuron/SC cultures at 1 and 5 dpl show the presence of SCs
whilemyelin degenerates. Open pink arrowheads showdegeneratedmyelin. The image on the bottom right (row 30 dpl) of the neuron/SCmodel is amagniﬁcation
of the region highlighted by a white box in the image on the left. Single optical sections displaying the highest signal intensity are shown. See also Figure S1.
(C) Live-cell imaging of GFP-labeled OLs interacting with DsRed-labeled axons in microgrooves before lesion and at 1 dpl and 3D surface rendering views
corresponding to the regions highlighted by white boxes on the left images (z series projections). Three-dimensional views labeled ‘‘1’’ and ‘‘2’’ correspond to two
different regions on the left image. See also Video S2.
Scale bars, 10 mm (A and B) and 25 mm (C). Representative images of at least three chambers for each type of culture (neuron/SC and neuron/OL) at each time
point are shown.
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Figure 3. SCs Induce Distal Cut Axons Fragmentation Shortly after Lesion
(A) Live-cell imaging (wide-ﬁeld) of DsRed-labeled axons inmicrogrooves of neuron + SC, neuron-only, or neuron +OL cultures within 10min after lesion (just after
lesion), at 12 hpl, and at 1 dpl.
(B) Quantiﬁcation showing the percentage of disintegrated axons (axon disintegration illustrated by Video S3) at 1 dpl in microgrooves of neurons + SCs, neurons
only, or neurons + OLs. Disintegration was quantiﬁed using time-lapse imaging. N = 3 chambers per group, axons of 50–100 microgrooves quantiﬁed per
chamber.
(C) Immunoﬂuorescence images of neuroﬁlament (NF) in cultures of neurons + SCs, neurons only, or neurons + OLs in unlesioned conditions (no lesion) and at
2 dpl. Single optical sections displaying the highest signal intensity are shown.
(D and E) Graphs showing the number of axonal fragments (D) and the percentage of fragments of different sizes (E) per microgroove in neuron + SC, neuron only,
and neuron + OL models just after lesion, at 12 hpl, and at 1 dpl. N = 3 chambers per group, 9–27 microgrooves quantiﬁed per chamber.
(legend continued on next page)
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To test whether VEGFR1 is involved in the control of actin dy-
namics in SCs after lesion, we ﬁrst validated Vegfr1 upregulation
by qRT-PCR in chamber 2 (Figure 5A) and found VEGFR1 protein
levels already upregulated in most SCs (93% ± 1%, n = 3 cham-
bers) at 12 hpl in our lesion model (Figure 5B). VEGFR1 was also
upregulated in SCs at 1 and 2 dpsnl in mice (Figures 5C, 5D, and
S4A), with 74% ± 10% VEGFR1-positive SCs (n = 3 animals),
suggesting important functions after lesion. Interestingly, the
activated form of VEGFR1 (phospho-VEGFR1) co-localized
with strings of actin spheres (Figure 5E), suggesting a potential
involvement of VEGFR1 activation in the formation of actin
spheres. Consistently, phospho-VEGFR1 levels were increased
in vivo in SCs at 1 dpsnl (Figure S4B). We thus blocked VEGFR1
activation by using a speciﬁc VEGFR1-neutralizing antibody.
This led in neuron/SC cultures to impaired formation of constrict-
ing actin spheres in SCs (Figure 5F), impaired SC-mediated
axonal fragmentation (Figure 5G), and decreased extent of
axonal regrowth (Figure S5A). To strengthen our data, we tested
the effect of the speciﬁc VEGFR1-neutralizing peptide GNQWFI
(Bae et al., 2005; Selvaraj et al., 2015) on axonal fragmentation
after lesion. We conﬁrm impaired SC-mediated axonal fragmen-
tation by using this second approach to inactivate VEGFR1 in
SCs (Figure S5B). Consistently, overexpressing VEGFR1 in
SCs accelerated the formation of strings of constricting actin
spheres and SC-mediated axonal fragmentation (Figure S5C;
Figure 5H; Video S6), demonstrating that VEGFR1 controls the
formation of constricting actin spheres in SCs, which mediate
axonal fragmentation.
Next, we aimed to elucidate how VEGFR1 is activated in SCs
after lesion. We hypothesized that a VEGFR1 agonist produced
by neurons upon lesion binds to VEGFR1 at the SC surface
and activates it. VEGFR1 can be activated by VEGFA, VEGFB,
or PlGF. To identify which VEGFR1 agonist activates VEGFR1 af-
ter lesion, we measured using ELISA the levels of each agonist
released in the medium of neurons only cultures at 1 dpl and
compared themwith unlesioned conditions. We found increased
PlGF release at 1 dpl compared to unlesioned conditions,
whereas the release of VEGFA and VEGFB was not signiﬁcantly
increased after lesion (Figure 5I). For this reason, we focused on
the potential functions of PlGF on VEGFR1 activation after lesion.
PlGF is known to be expressed in central and peripheral axons
(Beck et al., 2002; Chaballe et al., 2011). Although PlGF can be
soluble, it has been shown that a large fraction is retained at
the plasma membrane (Clegg and Mac Gabhann, 2017). Thus,
we investigated the presence of PlGF on the axolemma after
lesion. We show here that cell surface PlGF is strongly increased
at 12 hpl in distal cut axons compared with unlesioned axons
(chamber 2) or to the proximal part (chamber 1) of injured axons
(Figure 5J), whereas PlGF was not detected in SCs in unlesioned
conditions, at 12 hpl or at 1 dpl in our models (data not shown).
Importantly, inactivating PlGF with a speciﬁc neutralizing anti-
body impaired constricting actin sphere formation (Figure 5F)
and SC-mediated axonal fragmentation (Figure 5K) and
decreased the extent of axonal regrowth (Figure S5A). We also
tested the effect of PlGF downregulation by short hairpin RNA
(shRNA) in axons (Figure S5D). We show that this second
approach to inactivate PlGF in distal cut axons also leads to
reduced SC-mediated axonal fragmentation (Figure S5E). Local
translation in distal cut axons begins 10 min after axonal lesion
(Verma et al., 2005), thereby allowing rapid de novo protein
expression. Indeed, by blocking translation using cyclohexi-
mide, we prevented PlGF upregulation at the axonal surface (Fig-
ure 5L), suggesting lesion-induced local translation of PlGF in
distal cut axons. We next asked whether PlGF could modulate
VEGFR1 expression. Indeed, we show that treatment with
250 ng/mL PlGF for 24 h induces robust VEGFR1 upregulation
in puriﬁed rat SCs cultured under conditionsmimicking SCdedif-
ferentiation after lesion (Br€ugger et al., 2017; Figure 5M).
To link PlGF-mediated VEGFR1 activation to actin sphere for-
mation in SCs, we hypothesized that VEGFR1 activates Pak1, a
major inducer of actin dynamics (Kumar et al., 2006; Vadlamudi
et al., 2004; Edwards et al., 1999). Indeed, PlGF treatment
increased phospho-Pak1 (active Pak1) levels in SCs cultured
under dedifferentiation conditions (Figure 5N). Interestingly, we
found that phospho-Pak1 is highly concentrated inside actin
spheres (Figure 5O), suggesting an important function in the for-
mation of these actin structures. Indeed, we show that inhibition
of Pak1 using a Pak1-speciﬁc inhibitor (10 mM IPA-3) impaired
constricting actin sphere formation (Figure 5F) and SC-mediated
axonal fragmentation after lesion (Figure 5P). Consistently, we
found thatphospho-Pak1 levels increased in vivo inSCsat1dpsnl
(FiguresS4CandS4D). Pak1 is anactivator of theArp2/3complex
(Kumar et al., 2006; Vadlamudi et al., 2004), which initiates actin
polymerization. We show here that the speciﬁc Arp2/3 complex
inhibitor CK666 (100 mM) also leads to impaired SC-mediated
axonal fragmentation after lesion (Figure S5B), indicating an
involvement of the Arp2/3 complex in this mechanism.
To validate our ﬁndings in vivo, we ﬁrst treated adult mice
immediately after sciatic nerve crush lesion with the VEGFR1-
neutralizing peptide, which decreased VEGFR1 activation (phos-
phorylation) compared with vehicle treatment in sciatic nerves
(Figure 6A) and decreased Pak1 activation (Figure 6B). Consis-
tent with our in vitro ﬁndings, treatment with the VEGFR1-
neutralizing peptide strongly reduced the formation of actin
spheres at 1dpsnl compared with vehicle treatment and many
axonal fragments distal to the lesion site persisted at 2 dpsnl
(Figures 6C and 6D). Also similar to our cell culture ﬁndings,
PlGF was upregulated early in distal cut axons, already at 3 h
post-sciatic nerve crush lesion (hpsnl) (Figures 6E and 6F). At
this time point, SCs did not express PlGF, as shown by double
labeling of PlGF and MBP (used here as SC surface marker)
and 3D reconstruction (Figure 6E). PlGF is, however, upregulated
in SCs at 1 dpsnl (Chaballe et al., 2011, and data not shown),
where it may amplify SC reaction toward distal cut axons, or
(F) Selected 3D time-lapse photos of GFP-labeled SCs and DsRed-labeled distal cut axons a few hours after lesion (starting at 12 hpl for upper time-lapse and at
13 hpl for lower time-lapse) when breakdown of DsRed-labeled distal cut axons occurs. Entire time-lapse starting at 20 min after lesion is shown in Video S4.
Scale bars, 100 mm. Representative images of three chambers per condition are shown. Unpaired two-tailed Student’s t test compared with neurons + SCs: *p <
0.05, **p < 0.01, and ***p < 0.001; values are means; error bars denote SEM.
See also Figure S2.
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Figure 4. SCs Form Strings of Constricting Actomyosin Spheres after Lesion
(A) F-actin labeling (phalloidin) and neuroﬁlament (NF) immunoﬂuorescence in chamber 2 of neuron + SC model at 6 and 12 hpl and percentage of actin spheres
surrounding unfragmented distal cut axons (white arrows) and actin spheres surrounding axonal debris (blue arrowheads). Unpaired two-tailed (black crosses) or
one-tailed (gray asterisks) Student’s t test: *p < 0.05 and ++p < 0.01; n = 3 chambers per time point (6 hpl, 218–314 counted spheres per chamber; 12 hpl, 79–96
counted spheres per chamber); values are means; error bars denote SEM. Lower images are magniﬁcations of the regions highlighted by white boxes on the
upper images. Blue arrows indicate the constriction points on axons at the contact with actin spheres.
(legend continued on next page)
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control SC proliferation and/or macrophage recruitment, as pre-
viously proposed (Chaballe et al., 2011).
Importantly, to determine whether VEGFR1 expression is
required in SCs for distal cut axon disintegration after sciatic
nerve crush lesion, we ablated Flt1 (Vegfr1) speciﬁcally in adult
SCs. Mice expressing a tamoxifen-inducible Cre recombinase
under the control of the Plp promoter (Plp-CreERT2; Leone
et al., 2003) were crossed with mice carrying ﬂoxed Flt1 alleles
(Flt1ﬂ/ﬂ; Ho and Fong, 2015). At 3 months of age, Vegfr1 was ab-
lated in SCs by tamoxifen injection. To avoid potential compen-
satory mechanisms previously reported (Ho et al., 2012), we
used Plp-CreERT2-positive;Flt1ﬂ/wt heterozygous mutants (Flt1
mt) and Plp-CreERT2-negative;Flt1ﬂ/wt littermates as controls
(Ct). Ablating one Flt1 allele was sufﬁcient to block the upregula-
tion of VEGFR1 in SCs after lesion (Figures 6G and 6H), indi-
cating that a minimum threshold level of VEGFR1 expression
must be reached to allow upregulation after lesion. Furthermore,
ablation of one Flt1 allele signiﬁcantly reduced phospho-Pak1
levels at 1 dpsnl (Figure 6I). Consistent with our above ﬁndings,
the formation of actin spheres was strongly reduced at 1dpsnl
in Flt1 mt compared with control nerves (Figure 6J) and many
axonal fragments distal to the lesion site persisted at 2 dpsnl
(and at least until 5 dpsnl; data not shown) in the distal crushed
nerve of Flt1 mt but not of control mice (Figures 6K and 6L). To
determine whether axonal regrowth is affected in Flt1 mt sciatic
nerves, we used the marker of axonal regrowth growth-associ-
ated protein 43 (GAP43). We show here that GAP43 levels are
strongly reduced at 2 dpsnl in the distal crushed nerve of Flt1
mt compared with controls (Figures 6M and 6N), indicating
reduced axonal regrowth in Flt1 mt sciatic nerves and suggest-
ing that the persistence of distal axonal fragments in Flt1 mt
nerves slows down axonal regrowth, as expected from previous
studies (Wong et al., 2017; Vargas and Barres, 2007; Beirowski
et al., 2005; Martin et al., 2010; Brown et al., 1992; Chen and
Bisby, 1993). Consistent with slower axonal regrowth, functional
recovery of toe sensitivity was slower in Flt1 mt mice compared
with controls (Figure 6O).
Taken together, these results indicate that injured axons
instruct SCs to induce their disintegration by actin constriction
through a VEGFR1-Pak1-dependent pathway.
VEGFR1 Overexpression in OLs Promotes Distal Cut
Axon Disintegration
In contrast to SCs, VEGFR1 was not detected in OLs after
lesion in our lesion models or in unlesioned chambers (data
not shown). Consistent with this, mature (CC1+) OLs do not
express VEGFR1 or at very low levels (Figure S6A) and do
not upregulate VEGFR1 after a spinal cord lesion (Figure S6B).
However, PlGF was upregulated in central axons after a spinal
cord lesion (Figure S6C), suggesting that OLs do not upregu-
late VEGFR1 in the presence of PlGF. Indeed, PlGF did not
induce VEGFR1 expression in mature OLs (CC1+; Figure S6D).
We thus hypothesized that VEGFR1 may enable OLs to react
similarly as SCs in the presence of PlGF. Indeed, whereas
GFP-expressing mature OLs (primary cultures) did not activate
Pak1 in response to PlGF treatment, enforced expression of
VEGFR1 by lentiviral vector allowed Pak1 activation (as shown
by phosphorylated Pak1 signal) in the presence of 250 ng/mL
PlGF for 1 h in mature OLs (Figure 7A). In addition, overexpres-
sion of VEGFR1 also increased phospho-Pak1 levels in the
presence of PlGF in the Oli-neu OPC cell line differentiated
into mature OLs (Figure 7B). Consistent with this, VEGFR1
overexpression in primary OLs promoted distal cut axon disin-
tegration within 1 dpl, compared with the disintegration of
distal cut axons in the presence of primary OLs transduced
with a control lentivirus (Figures 7C and 7D). Three-dimensional
time-lapse imaging of GFP-labeled processes of primary
OLs overexpressing VEGFR1 showed that these processes
enwrap distal cut axons after lesion until their disintegration
(Figure 7E). Consistently, time-lapse imaging of F-actin (labeled
by LifeAct-GFP) of primary OLs overexpressing VEGFR1
showed increased actin polymerization in OLs after lesion
around unfragmented distal cut axons until their disintegration
(Figures 7F and 7G; Video S7). Constriction of axons at the
contact points with F-actin until their disintegration indicates
that OLs overexpressing VEGFR1 are capable, similarly to
SCs, of promoting distal cut axon disintegration by actin
constriction. Consistent with faster distal cut axon disintegra-
tion, the extent of axonal regrowth was signiﬁcantly increased
in the presence of primary OLs expressing VEGFR1 compared
with GFP control OLs (Figure S2).
(B) F-actin labeling (phalloidin) and bright-ﬁeld images at 12 hpl in neuron/SC cultures. Pink arrows point to funnel-shaped actin accumulation at myelin ovoids
(Jung et al., 2011) visible in bright ﬁeld, while white arrows indicate actin spheres. Note that strings of constricting actin spheres are distinct from funnel-shaped
actin and are not localized at degenerated myelin. Lower images are magniﬁcations of the regions highlighted by dashed boxes on the upper images. Single
optical sections are shown.
(C) Three-dimensional reconstruction of F-actin surface rendering and NF at 12 hpl showing actin spheres (white arrows) surrounding an unfragmented axon that
is expanded (white arrowheads) in the actin spheres. See also Video S5.
(D) F-actin co-labeling with NF in chamber 2 of neuron/SC cultures after lesion showing different axonal morphology inside actin spheres, illustrating the
constriction-expansion of distal cut axons. White arrows point to expanded axons inside actin spheres and blue arrows to constricted axonal regions at the
contact points with actin spheres.
(E) Time-lapse imaging of DsRed-labeled axons and LifeAct-GFP-labeled SC in microgroove. White arrows indicate the formation of actin spheres and blue
arrows the constriction points on the axon. Other unlabeled SCs present in the microgroove are shown by red asterisks.
(F) F-actin co-labeling with myosin heavy chain 1 (white arrows show actomyosin spheres). Lower images are magniﬁcations of the region highlighted by dashed
boxes on the upper images.
(G) F-actin co-labeling with NF in cryosections of mouse sciatic nerve at 1 dpsnl showing expanded-constricted axons (blue arrowheads) surrounded by
actin spheres (white arrows). Images are z series projections or 3D views (upper 3D view images show the staining and lower images are 3D surface
rendering).
Scale bars, 25 mm (A) and 10 mm (B and D–G). Representative images of three chambers per condition or of three animals are shown.
See also Figures S3 and S4.
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Figure 5. Axonal PlGF Activates VEGFR1-Dependent Actin Dynamics in SCs, Leading to Distal Cut Axon Fragmentation
(A) Vegfr1 mRNA levels quantiﬁed by qRT-PCR in SCs (chamber 2) showing increased levels at 1dpl compared with unlesioned conditions (Ctrl).
(B) VEGFR1 immunoﬂuorescence and DAPI labeling (nuclei) in chamber 2 of neuron/SC model at 12 hpl and in unlesioned conditions.
(C) VEGFR1 and F4/80 (macrophage marker) co-immunoﬂuorescence and DAPI (nuclei) labeling in unpermeabilized conditions in crushed and contralateral
uninjured mouse sciatic nerves at 1 dpsnl.
(D) Western blot of VEGFR1 and GAPDH (loading control) in lysates of crushed (Cr) compared with unlesioned contralateral (Co) mouse sciatic nerves at 12 hpsnl
and 1, 2, and 5 dpsnl and quantiﬁcation normalized to GAPDH.
(E) F-actin (phalloidin) and phospho-VEGFR1 (activated VEGFR1) co-labeling in neurons + SCs at 6 hpl showing co-localization of phospho-VEGFR1 with actin
spheres (white arrows) and actin between spheres (blue arrowheads).
(F) F-actin and neuroﬁlament (NF) co-labeling and percentage of axons with actin spheres (axons with at least one actin sphere) in neuron + SC model at 12 hpl
showing expanded axons (blue arrowheads) within constricting actin spheres (white arrows) in the presence of a PlGF neutralizing or a VEGFR1-neutralizing
antibody, a Pak1-speciﬁc inhibitor, or the vehicle added to the culture medium 1 h before lesion.
(G) DsRed-labeled neurons (cultured with SCs) treated with the VEGFR1-neutralizing antibody or IgG control 1 h before lesion and quantiﬁcation at 12 hpl of
remaining distal cut axons compared with control.
(H) Time-lapse images 10 min after lesion, 6 and 9 hpl of DsRed-labeled axons and LifeAct-GFP-labeled SCs (see also Figure S5 and Video S6) expressing
endogenous levels of VEGFR1 (control) or overexpressing VEGFR1 (VEGFR1over) by lentiviral vector and graph showing the percentage of axons disintegrating
at each hour from 5 to 13 hpl (no axon disintegrated before 5 hpl).
(I) PlGF, VEGFA, and VEGFB levels determined as fold increase at 1 dpl compared with unlesioned conditions (Ctrl; set to 1) by ELISA on supernatants of
microﬂuidic chambers containing puriﬁed neurons. PlGF concentration range, 1–10 pg/mL; VEGFA concentration range, 100–400 pg/mL; VEGFB concentration
range, 4–18 pg/ml. The contents of three chambers were pooled for each n.
(J and L) PlGF immunoﬂuorescence in puriﬁed neurons at 12 hpl in chamber 1 (axons proximal to the lesion site) or chamber 2 (distal cut axons) mergedwith bright
ﬁeld in untreated conditions (J) or treated with cycloheximide (CHX) or its vehicle in chamber 2 just before lesion (L).
(K and P) NF immunoﬂuorescence in neuron + SC cultures treated 1 h before lesion with the PlGF-neutralizing antibody or control IgG (K) or with the Pak1-speciﬁc
inhibitor IPA-3 or its vehicle (P) and quantiﬁcation of remaining distal cut axons using NF signal and Cell Proﬁler 2.0.
(M and N) Western blots of VEGFR1 (M) or phospho-Pak1 (N) in primary dedifferentiated SCs treated with 250 ng/mL PlGF or vehicle for 24 h and quantiﬁcation
normalized to GAPDH. Dashed lines indicate that samples were run on the same gel but not on consecutive lanes.
(O) F-actin and phospho-Pak1 co-labeling in neurons + SCs at 6 hpl showing clustering of phospho-Pak1 signal inside actin spheres (white arrows).
In (B) and (C), arrows point to SCs and arrowheads to macrophages. Scale bars: white, 10 mm; black, 250 mm. Unpaired (A, F, H, M, and N) or paired (D, G, and I)
two-tailed (black asterisks) or one-tailed (gray asterisks) Student’s t test: *p < 0.05, **p < 0.01, and ***p < 0.001; values are means; error bars denote SEM (A, D,
F–H, K, M, N, and P: n = 3 per group; I: n = 3–7 per group). Representative images of three independent experiments are shown.
9
htt
p:/
/do
c.r
ero
.ch
Figure 6. Speciﬁc Inactivation or Genetic Ablation of VEGFR1 Impairs Distal Cut Axon Disintegration after Sciatic Nerve Crush Lesion
(A) Phospho-VEGFR1, S100 (SCmarker), and F4/80 (macrophagemarker) co-immunoﬂuorescence and DAPI (nuclei) labeling at 2 dpsnl in crushed sciatic nerves
of mice treated with the VEGFR1-neutralizing peptide compared with crushed sciatic nerves of vehicle-treated mice. Arrows point to SCs and arrowheads to
macrophages.
(B–D) Phospho-Pak1 western blot and quantiﬁcation normalized to GAPDH (B) and F-actin (phalloidin) labeling (C) or neuroﬁlament (NF) immunoﬂuorescence (D)
together with DAPI labeling in crushed sciatic nerves of VEGFR1-neutralizing peptide-treated compared with vehicle-treated mice collected at 1 dpsnl (B and C)
or at 2 dpsnl (D).
(E and F) PlGF co-immunoﬂuorescence with MBP (E) or NF (F) and DAPI at 3 hpsnl in crushed and contralateral mouse sciatic nerves. Three-dimensional view:
region highlighted by dashed box on left image.
(legend continued on next page)
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DISCUSSION
To identify and modulate plasticity mechanisms of the nervous
system after lesion, it is of utmost importance to use models al-
lowing the measurement of dynamic cell plasticity parameters
and to analyze at the molecular level the contribution of each
cell type involved. Models currently available comprise various
in vivo paradigms of PNS and CNS lesions, which are instru-
mental to study regeneration and functional recovery at the or-
ganism level but imply limitations: in vivo live imaging is restricted
in depth or limited to non-mammalian organisms, and system-
atic analyses such as RNA-seq are difﬁcult to interpret because
of the cellular complexity of the nervous system. State-of-the-art
in vitro myelinated regeneration models allow compartmentali-
zation of neuronal soma, axons, and glial cells (Taylor et al.,
2005; Park et al., 2006) but are currently restricted to the evalu-
ation of axonal regrowth density and neuron transcript analyses
in the absence of glial cells. Here we developed lesion models of
myelinated mammalian systems for the study of plasticity mech-
anisms after lesion and the design of strategies to increase plas-
ticity and improve regeneration of the PNS and CNS (i.e., drug
screening for regenerative medicine). We show that these
models allow high-resolution time-lapse imaging of neuron-glial
cell interactions after lesion and transcriptomic analyses in pure
or highly enriched neuron or glial cell populations. We also
demonstrate that these lesion models recapitulate each step of
the regeneration process in the PNS with similar timing as in vivo
and regeneration failure occurring in the CNS after lesion. In
addition, ﬂux isolation and dual-color imaging allow separately
modulating gene expression in neurons and glial cells and iden-
tify plasticity mechanisms to test strategies enhancing regener-
ation of the nervous system after lesion. These systems can thus
be used to speed up the discovery of potential treatments to be
afterward tested in vivo.
Importantly, by using these models, we demonstrate that
shortly after lesion, SCs promote distal cut axon disintegration
to accelerate their clearing. SCs are known to phagocytose
axonal debris and digest their own myelin after lesion (Jessen
and Mirsky, 2016; Wong et al., 2017), but axons need ﬁrst to
be disintegrated into small fragments to be phagocytosed. Distal
cut axon disintegration is thought to be an axon-inherent mech-
anism (Raff et al., 2002), but we show here that this process is
slow in the absence of SCs and that SCs induce the breakdown
of distal cut axons within a few hours after axonal lesion. We
demonstrate that SC-dependent disintegration of axons is
induced by VEGFR1 activation in SCs. Indeed, after axonal
lesion, VEGFR1 is rapidly upregulated and activated in SCs by
the VEGFR1 agonist PlGF, which is locally translated in distal
cut axons upon lesion. Local protein translation in distal cut
axons is a process that has been previously shown to begin
10 min after axonal lesion (Verma et al., 2005). We show that
axonal lesion induces a modest but signiﬁcant extracellular
release of PlGF and a strong increase of PlGF at the outer surface
of distal cut axons but not at the surface of proximal cut axons
attached to the neuron soma. In addition, we show that antago-
nizing PlGF impairs SC-mediated distal cut axon disintegration.
These ﬁndings indicate that PlGF instructs SCs to induce distal
cut axons disintegration. It has been shown that PlGF is also up-
regulated in SCs at 1 dpsnl (Chaballe et al., 2011), an observation
that we also made. However, PlGF is upregulated earlier in distal
cut axons, already at 3 hpsnl, a time point when PlGF expression
is not detected in SCs. Furthermore, in our lesion models, we
could not detect PlGF expression in SCs in unlesioned condi-
tions, at 12 hpl or at 1 dpl, a time point when VEGFR1 is already
upregulated in SCs and when SC-dependent axonal disintegra-
tion through VEGFR1 activation has already taken place. PlGF
upregulation at 1 dpsnl in SCs may amplify SC reaction toward
distal cut axons by an autocrine mechanism. Alternatively,
PlGF upregulation in SCs may control SC proliferation and/or
macrophage recruitment after lesion, as previously suggested
(Chaballe et al., 2011). However, in our lesion models, SCs do
not proliferate after lesion, and macrophages are absent; thus
SC proliferation and/or macrophages do not contribute to SC-
dependent axonal disintegration.
In addition, we demonstrate that VEGFR1 activation in SCs
leads to the activation of Pak1, a major activator of actin dy-
namics that acts through the activation of the Arp2/3 complex
(Kumar et al., 2006; Vadlamudi et al., 2004) and LIM kinases (Ed-
wards et al., 1999). We also show that Pak1 activation is required
for SC-dependent axonal fragmentation. The signals by which
axonal lesion induces SC responses are partially understood.
Here, we identify a molecular mechanism by which distal cut
axons signal to SCs and which is required to activate SC-depen-
dent disintegration of distal cut axons.
Interestingly, we show that the PlGF/VEGFR1/Pak1 axis leads
to the formation of strings of actin spheres in SCs along unfrag-
mented axons, which constrict distal cut axons at their points of
contact with axons, thereby leading to axonal expansion within
the spheres until complete axonal disintegration. We show that
SC actin spheres form independently of myelin ovoids. It has
(G andH)Western blot of VEGFR1 andGAPDH loading control (G) and co-immunoﬂuorescence of VEGFR1, S100, and F4/80 together with DAPI labeling (H) in the
crushed (Cr) or uninjured contralateral (Co) sciatic nerve of Flt1 mt mice compared with control littermates (Ct) at 2 dpsnl.
(I, K, andM)Western blots of phospho-Pak1 (I), NF (K), or GAP43 (M) andGAPDH loading control and quantiﬁcation of phospho-Pak1, NF, andGAP43 normalized
to GAPDH in sciatic nerves of Flt1 mt mice compared with Ct at 1 dpsnl (phospho-Pak1) or at 2 dpsnl (NF and GAP43; values were normalized to the uninjured
contralateral nerve [‘‘Co’’] of each animal).
(J, L, and N) F-actin labeling (phalloidin) (J), NF (L), or GAP43 (N) immunoﬂuorescence and DAPI labeling in distal crushed nerves of Flt1mtmice and Ct at 1 dpsnl
(J) or at 2 dpsnl (L and N).
(O) Quantiﬁcation of sensory function recovery by toe pinch test at 12, 15, and 20 dpsnl in Flt1 mt and control mice.
In (G) and (I), the dashed lines indicate that samples were run on the same gel but not on consecutive lanes. In (C) and (J), arrowheads point to strings of actin
spheres. Scale bars: 10 mm (A, E, F, and H), 20 mm (C), 50 mm (J), 250 mm (N), and 500 mm (D and L). Unpaired (M and O) or paired (B, I, and K) one-tailed (gray
asterisk) or two-tailed (black asterisks) Student’s t test: *p < 0.05 and **p < 0.01; values are means; error bars denote SEM. In (A) and (N), n = 3 animals per group;
in (O), n = 4–9 animals per group (n = 9 for Ct and n = 6 for Flt1mt at 12 and 15 dpsnl, n = 6 for Ct and n = 4 for Flt1mt at 20 dpsnl). Representative images (z series
projections or 3D views) of three animals per group for each experiment are shown.
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been previously shown that funnel-shaped F-actin is present at
Schmidt-Lantermann incisures in intact peripheral nerves and
is necessary for the formation of myelin ovoids after lesion
(Jung et al., 2011). VEGFR1-dependent actin spheres that we
identify here are dedicated to the disintegration of distal cut
axons and are not involved in myelin ovoid formation. Interest-
ingly, three key genes for the formation of myosin ﬁlaments
and myosin contraction were upregulated in our RNA-seq ana-
lyses in SCs at 1 dpl: Myh1, Myom1, and Casq2. Indeed, we
found that myosin heavy chain 1 co-localized with F-actin at
the spheres in SCs after lesion, indicating the formation of con-
stricting actomyosin spheres. The formation of such structures
(spheres or rings) has been previously described to serve other
cellular processes, including cytokinesis, wound closure, and
Figure 7. Enforced Expression of VEGFR1 in OLs Promotes Distal Cut Axon Disintegration
(A) Phospho-Pak1, CC1 (mature OL marker, false-colored in green), and DAPI (nuclei) co-labeling in primary OLs cultured under differentiation conditions,
transduced with a control lentivirus or a lentivirus expressing VEGFR1 and treated with 250 ng/mL PlGF for 1 h. Arrows show CC1+ cells. Representative images
of three independent experiments are shown.
(B) Western blot of phospho-Pak1 in Oli-neu cells differentiated into mature OLs and transduced with GFP or VEGFR1-expressing lentiviruses and treated with
PlGF for 1 h and quantiﬁcation normalized to GAPDH. Three independent experiments were carried out per condition.
(C and D) Live-cell imaging of DsRed-labeled axons and GFP-labeled OLs transduced with a VEGFR1-expressing or a control (GFP) lentiviral vector (C) and graph
showing the percentage of disintegrated axons at 1dpl (D). The course of axon disintegration was followed by time-lapse imaging, 6–23 axons were followed for
each time-lapse, and three to ﬁve time-lapses per condition were used for quantiﬁcation.
(E–G) Live-cell imaging of DsRed-labeled axons and (E) GFP-labeled or (F and G) LifeAct-GFP-labeled OLs transduced with a VEGFR1-expressing or a control
(empty) lentiviral vector.
In (C) and (E)–(G), OLs were ﬁrst transduced with high-titer VEGFR1-expressing lentiviruses or control lentiviruses and 3 days later with high-titer GFP-expressing
lentiviruses (C and E) or high-titer LifeAct-GFP lentiviruses (F and G). Images shown are z series projections (A, C, and F) and time-lapse 3D surface rendering
(E and G). Arrows show OL processes (E) or F-actin (F and G) enwrapping DsRed-labeled axons. Blue arrowheads indicate constriction points by actin on axons.
Scale bars, 10 mm. Unpaired two-tailed Student’s t tests: *p < 0.05 and **p < 0.01; values are means; error bars denote SEM.
See also Figure S6 and Video S7.
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epithelial cell extrusion (Schwayer et al., 2016). In addition, non-
constricting actin ring-like structures are used for cell-cell
contacts (Schwayer et al., 2016). We demonstrate here that
constricting actin spheres are also instrumental for the disin-
tegration of damaged axons, as a result of a collaborative
crosstalk between distal cut axons and SCs. Interestingly and
reminiscent of the pro-disintegrating functions of SCs on distal
cut axons after lesion, Han et al. (2014) showed in Drosophila
that epidermal cells, rather than just internalizing disintegrated
dendrite pieces, wrap degenerating dendrites with actin-rich
membrane structures to facilitate dendrite breakdown (Han
et al., 2014).
In contrast to SCs, OLs do not exhibit plasticity behaviors after
axonal lesion. Instead, they remain at their myelinating state in
the lesion site or die, and their myelin, which contains growth-
inhibitory factors, is not cleared and prevents axonal regrowth
(Brosius Lutz and Barres, 2014). We show that OLs do not upre-
gulate VEGFR1 after axonal lesion, despite the upregulation
of PlGF at the surface of CNS axons after spinal cord injury.
However, enforced expression of VEGFR1 in OLs using lentiviral
vectors induces distal cut axons fragmentation to a similar level
as in neuron/SC cultures after lesion and promotes axonal
regrowth in our in vitro lesion models: similar to SCs but in
contrast to wild-type OLs, OLs overexpressing VEGFR1 ex-
hibited motility around distal cut axons after lesion, encircling
distal cut axons with F-actin until their disintegration. However,
OLs overexpressing VEGFR1 did not form the same actin sphere
morphology as SCs. It is possible that the different inherent
cellular morphology of SCs and OLs and their different abilities
to interact with axons lead to the formation of different actin
structures to mediate axonal disintegration after lesion.
In summary, this study identiﬁes a mechanism of SC plasticity
that occurs within a few hours following axonal lesion and that is
essential for rapid disintegration of distal cut axons. This mech-
anism, which is triggered by distal cut axons upregulating PlGF
after lesion and thereby activating VEGFR1 in SCs, can be ac-
quired by OLs through enforced expression of VEGFR1. This
work thus provides a proof of concept for a strategy to help
modulating SC and OL plasticity in the PNS and CNS and
thereby opens potential avenues to enhance regeneration of
the PNS and CNS after injury.
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STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit anti-VEGFR1 Abcam Cat#ab32152; RRID:AB_778798
Rabbit anti- phospho(S204)-PAK1 Abcam Cat#ab79503; RRID:AB_1658891
Rabbit anti-Neuroﬁlament Millipore Cat#AB1987: RRID:AB_91201
Rabbit anti-GAP43 Abcam Cat#ab75810; RRID:AB_1310252
Mouse anti-GAPDH Genetex Cat#GTX28245; RRID:AB_370675
Rabbit anti-cJun Abcam Cat#ab32137; RRID:AB_731608
Rat anti-MBP Serotec Cat#MCA409S; RRID:AB_325004
Rabbit anti-Sox10 DCS Innovative Diagnostik-Systeme Cat#SI058C01; RRID:AB_2313583
Mouse anti-CC1 Millipore Cat#OP80; RRID:AB_2057371
Rat anti-F4/80 Genetex Cat#GTX26640; RRID:AB_385952
Rabbit anti-cleaved Caspase 3 Cell Signaling Cat#9661; RRID:AB_2341188
Rabbit anti-PlGF Abcam Cat#ab196666
Rabbit anti-phospho-VEGFR1 (Tyr1213) Millipore Cat#07-758; RRID:AB_492649
Mouse anti-Myosin heavy chain 1, fast, 2x Developmental Studies
Hybridoma Bank
Cat#6H1; RRID:AB_1157897
Rat anti-PlGF (neutralizing antibody) Novus Cat#NBP2-21953
Mouse anti-VEGFR1 (neutralizing antibody) R&D Systems - Bio-techne Cat#AF471; RRID:AB_355379
Mouse anti-IgG R&D Systems - Bio-techne Cat##AB-108-C; RRID:AB_354267
Bacterial and Virus Strains
Lentivirus: pLV-LSyn-RFP Nathanson et al., 2009 Addgene construct#22909
Lentivirus: LentiLox 3.7 [pLL3.7] ATCC ATCC VRMC39
Lentivirus: Lifeact-GFP Dr. Olivier Pertz, University of Bern,
Switzerland
N/A
Lentivirus: Lenti-ORF clone of FLT1 (mGFP-tagged)-
Human fms-related tyrosine kinase 1
Origene Cat#RC224406L2
Lentivirus: PlGF shRNA Sigma Cat#SHCLNG, TRCN0000065844
Lentivirus: Control shRNA Sigma Cat#PLK0.1
Chemicals, Peptides, and Recombinant Proteins
anti-Flt1 peptide: GNQWFI Bio-Synthesis 10581-01
Tamoxifen Sigma T5648
IPA-3 (Pak1 inhibitor) Selleckchem Cat#S7093
CK666 (Arp2/3 complex inhibitor) Sigma Cat#SML0006
Recombinant Mouse PlGF-2 Protein R&S Systems 465-PL-010
Phalloidin-iFluor 488 Reagent – CytoPainter Abcam Cat#ab176753
Rhodamine Phalloidin ThermoFisher Cat#R415
Critical Commercial Assays
Click-iT Plus EdU Alexa Fluor 647 Imaging Kit Life Technologies Cat#C10640
Rat Vascular Endothelial Growth Factor A ELISA Kit MyBioSource.com Cat#MBS748119
Placenta Growth Factor ELISA kit MyBioSource.com Cat#MBS727112
Vascular Endothelial Growth Factor B (VEGF-B) ELISA kit MyBioSource.com Cat#MBS269676
Deposited Data
RNaseq data This study ENA: PRJEB32448
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulﬁlled by the Lead Contact, Claire
Jacob (cjacob@uni-mainz.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Mice were housed in individually ventilated cages and had free access to water and food. We used adult mice of mixed background
backcrossed several times to C57BL/6J. Sciatic nerve crush lesions were carried out on 3 to 4-month old male and female mice, as
previously described (Br€ugger et al., 2017). No randomization method was used, but experimenters were blinded to the experimental
group (treatment) and received only the animal number given at birth by the animal caretaker. As control vehicle mice, we used litter-
mate mice of the same sex. Treatments: 100 ml of 1 mg/ml VEGFR1 neutralizing peptide (GNQWFI, Bio-Synthesis) or its vehicle (6%
DMSO, 0.01% acetate/PBS) were injected in the pelvic cavity after wound closure. Spinal cord hemisections were carried out at T8
level on 3 to 4-month old male and female mice as described (Ghosh et al., 2009). Mice heterozygous for Flt1 ﬂoxed allele (Ho and
Fong, 2015, The Jackson Laboratory) were crossed with mice expressing tamoxifen-inducible Cre recombinase under control of the
SC-speciﬁc Plp promoter (Leone et al., 2003). To ablate VEGFR1, mice received daily injections of 2 mg tamoxifen (Sigma) for ﬁve
consecutive days and lesions were done 3 weeks post tamoxifen injections. Genotypes were determined by PCR on genomic DNA.
Animal use was approved by the Veterinary ofﬁce of the Canton of Fribourg.
DRG neurons/SC cultures
DRG explants were collected from embryonic day (E) 14.5-15.5Wistar rat embryos and dissociated as previously described (Br€ugger
et al., 2015). The detailed culture protocol is described below in the section entitled ‘‘Set up and optimization of microﬂuidic models.’’
In some cases, cells were treated with 100 mM cycloheximide (only in chamber#2, just before lesion) to inhibit mRNA translation into
protein. In other cases, cells were treated with PlGF neutralizing antibody (43.75 mg/ml, Novus, cat. #NBP2-21953), VEGFR1 neutral-
izing antibody (43.75 mg/ml, R&DSystems - Bio-techne, cat. #AF471-SP) or IgG control (43.75 mg/ml, R&DSystems - Bio-techne, cat.
#AB-108-C) or with the speciﬁc Pak1 inhibitor IPA-3 (10 mM, Selleckchem, cat. #S7093) or with the speciﬁc Arp2/3 complex inhibitor
CK666 (100 mM, Sigma, cat. # SML0006) or with the VEGFR1 neutralizing peptide GNQWFI (1 mg/ml, Bio-Synthesis) or their vehicle
1 h before lesion. In other cases, neurons were transduced with lentiviral vectors carrying either a PlGF shRNA (Sigma, mission
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Experimental Models: Cell Lines
Rat dorsal root ganglia dissociated explant culture This study N/A
Primary rat dorsal root ganglia neuron This study N/A
DRG neurons/Primary rat oligodendrocyte cultures This study N/A
Primary rat Schwann cell cultures This study N/A
Oli-neu cell line Jung et al., 1995 N/A
Experimental Models: Organisms/Strains
Mouse: C57BL/6J Plp-CreERT2+;Flt1ﬂ/wt mutant:
PLP-CreERT2;Flt1tm1.1Fong
Leone et al., 2003; Ho and Fong, 2015
(The Jackson Laboratory)
N/A
Mouse: C57BL/6J Plp-CreERT2-;Flt1ﬂ/wt Control: Flt1tm1.1Fong Ho and Fong, 2015 (The Jackson
Laboratory)
N/A
Oligonucleotides
rat Vegfr1-Forward: 50-GTGTCTATAGGTGCCGAGCC-30 Microsynth N/A
rat Vegfr1-Reverse: 50-GGGTGATCAGCTCCAGGTTT-30 Microsynth N/A
rat Gapdh-Forward: 50-GTATCCGTTGTGGATCTGACAT-30 Microsynth N/A
rat Gapdh-Reverse: 50-GCCTGCTTCACCACCTTCTTGA-30 Microsynth N/A
Software and Algorithms
vaquiea/VisiView_Stack-Assembler v1.0 This study https://zenodo.org/record/844628
Fiji Preibisch et al., 2009 N/A
STAR 2.5.0b Dobin et al., 2013 N/A
Imaris 9.3 https://imaris.oxinst.com/products/
imaris-single-full
N/A
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shRNA, cat. # SHCLNG, TRCN0000065844) or a Control shRNA (Sigma, PLK0.1) 1 week before lesion for neuron-only cultures and
before switching to the differentiation medium in neurons+SCs cultures.
DRG neurons/primary OL cultures
DRG neurons isolated as described above (for DRG neurons/SC cultures) but were puriﬁed to eliminate all proliferating cells by a
supplement of 1 mMFUDR (5-Fluoro-2-deoxyuridine, Sigma). The detailed culture protocol is described below in the section entitled
‘‘Set up and optimization of microﬂuidic models.’’ Primary rat OLs were puriﬁed in parallel and inserted in chamber#2. Rat OPC
cultures were prepared from cortices of postnatal day (P) 1-2 Wistar rat pups as described (Chen et al., 2007). Some modiﬁcations
were done from the 2nd step, ‘‘isolation and culture,’’ to adapt the culture to microﬂuidic chambers: at the 11th day of culture after
puriﬁcation, puriﬁed primary rat OPCs were inserted in chamber#2.
Primary rat SC cultures
Puriﬁed primary rat SC cultures were obtained from sciatic nerves of Wistar newborn (P2) rats as described (Jacob et al., 2008). SCs
were treatedwith 250 ng/ml PlGF (R&DSystems, Cat# 465-PL-010) or its vehicle in dedifferentiating culture conditions (Br€ugger et al.,
2017) for 24 h.
Oli-neu cultures
The OPC cell line Oli-neu (Jung et al., 1995) was kindly provided by Dr. Jacqueline Trotter (University of Mainz, Germany). Oli-neu
cells were grown as described (Gokhan et al., 2005). For differentiation, Oli-neu cells were maintained for 3 days in the following
medium: DMEM containing 2 mM L-glutamine and 1 mM sodium pyruvate, supplemented by 100 mg/ml apotransferrin, 5 mg/ml
insulin, 60 nM triiodothyronine, 30 nM sodium selenite, 60 ng/ml progesterone, 16 mg/ml putrescine and 0.2% Penicillin-Strepto-
mycin. For western blot analyses, Oli-neu cells were then transduced with lentiviruses expressing either GFP or VEGFR1 and
3 days after transduction they were treated with 250 ng/ml PlGF for 1 h.
METHOD DETAILS
Western blot
Toquantifyprotein levels inmousesciatic nervesandprimary ratSCs,westernblotswerecarriedout, aspreviouslydescribed (Br€ugger
et al., 2017). Primary antibodies: VEGFR1 (rabbit, 1:1000, Abcam, cat. #ab32152), phospho(S204)-PAK1 (rabbit, 1:500, Abcam, cat.
#ab79503), Neuroﬁlament (rabbit, 1:1000, Millipore, cat. #AB1987), GAP43 (rabbit, 1:100 000, Abcam, cat. #ab75810), GAPDH
(glyceraldehyde-3-phosphate-dehydrogenase,mouse, 1:5000, Genetex, cat. #GTX28245). Secondary antibodieswere fromJackson
ImmunoResearch: light chain-speciﬁc goat anti-mouse-HRP (horse radish peroxidase) and goat anti-rabbit-HRP.
Set up and optimization of microﬂuidic models
We used microﬂuidic devices to set up lesion models of neurons cultured alone or in the presence of SCs or OLs. These models
allowed us to separate the nuclei of neurons and myelinating cells, the distal part of cut axons and the proximal part attached to
the neuron cell body, and to follow the disintegration and regrowth of individual axons and the dynamic interaction of axonswithmye-
linating cells at the single cell level over several days. Microﬂuidic chambers were generated as previously described (Taylor et al.,
2005). Surfaces of microﬂuidic chamber devices and glass coverslips were activated using a plasma cleaner (Femto system, Diener
Electronic) using a plasma air (0.6 mbar, 100 W for 0.1 min) to stick a glass coverslip to each microﬂuidic device and render PDMS
surfaces hydrophilic.
We used two different microﬂuidic chamber designs, one symmetric with two equally sized chambers (Length: 1 cm, Height:
100 mm,Width: 1.5mm) connected by 200 longmicrogrooves (L: 1.5mm, H: 3 mm,W: 10 mm) and one asymmetric with two differently
sized chambers (small chamber, L: 1 cm, H: 100 mm,W: 1.5mm; large chamber, L: 1 cm, H: 100 mm,W: 5mm) connected by 200 short
microgrooves (L: 0.5 mm, H: 3 mm,W: 10 mm). In addition, two wells (diameter: 6 mm) are connected to each chamber to allow plating
of cells, culture medium change, supernatant and cell lysate collection.
After UV irradiation and poly-D-lysine coating of the chambers, eight microliters of dissociated DRG explants (corresponding to6
DRG) prepared as described (Br€ugger et al., 2015) and re-suspended in expansion medium (NBmedium) were added to chamber#1.
To favor expansion of axons through themicrogrooves and spreading into chamber#2, we added a larger volume (60 ml per well) of NB
medium in chamber#1 as compared to chamber #2 (50 ml per well), and we applied a nerve growth factor (NGF) gradient: 33 ng/ml in
chamber#1 and 100 ng/ml in chamber#2. To obtain amodel of neuronsmyelinated by SCs, wemaintained these culture conditions for
1 week with NB medium replacement every 2-3 days. We then switched to differentiation medium (C-medium) to induce myelination
and applied a milder NGF gradient: 33 ng/ml in chamber#1 and 50 ng/ml in chamber#2 for three weeks with C-medium replacement
every 2-3 days. For live-cell imaging, we labeled neurons in red by adding to chamber#1 0.5 ml of a highly concentrated lentivirus
generated as previously described (Br€ugger et al., 2015) and which expresses DsRed under control of the neuron-speciﬁc Synapsin
promoter. We labeled SCs in green by adding to chamber#2 a highly concentrated lentivirus (0.5 or 2.0 ml, depending on transduction
rate needed) expressing GFP of Lifeact-GFP under control of the CMV promoter. Although the CMV promoter is active in neurons,
only SCs were labeled in green under these conditions and neurons did not get labeled in green or rarely (0-2 neurons per device).
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To obtain a model of neurons myelinated by OLs, DRG neurons were puriﬁed by killing dividing cells with 1 mg/ml FUDR added to
NBmedium alternating with NBmedium alone, for 3 cycles of 23 2-3 days starting the day after DRG plating. Puriﬁed neurons were
kept afterward in NB medium for another week to completely remove FUDR. Up to this point, the NGF gradient of 33 ng/ml in
chamber#1 and 100 ng/ml in chamber#2 was maintained. In the meantime, oligodendrocyte precursor cells (OPCs) were prepared
from rat cortices as described (Chen et al., 2007). Sixty microliters of highly enriched OPCs (containing70,000 cells) re-suspended
in OL differentiation medium (Chen et al., 2007) were added to one well of chamber#2, allowed to spread in the chamber for 15 min
before adding 50 ml of OL differentiation medium into the same well. The culture was maintained under these conditions for 3 weeks.
For live-cell imaging neurons were labeled in red (with the Synapsin-DsRed lentivirus) after their puriﬁcation and OLs in green by
adding to chamber#2 0.5 or 2.0 ml of lentivirus expressing GFP or Lifeact-GFP.
NGFwas removed from culturemedia 24 h before carrying lesions. For RNA sequencing analyses, immunoﬂuorescence and ELISA
in chamber#2, we sectioned all axons of all microgrooves. For live-cell imaging in microgrooves, we sectioned axons of 10 to 200
microgrooves for 2D imaging and of 1 to 10 microgrooves for 4D imaging. Laser pulses efﬁciently sectioned axons in less than a
second per microgroove.
Live cell microscopy and image processing of lesion models
To image the interaction between axons and SCs or OLs, we used 3D imaging. To image axonal disintegration and regrowth, we used
2D imaging.
For 2D imaging, we used a CSU-W1 spinning disk microscope to acquire wide-ﬁeld images at 20 min intervals on several stage
positions (3 to 6with at least 10% image frame overlap) during 24 to 48 h (for movie reconstruction) or at 24 h intervals on 3 to 60 stage
positions during 4 to 40 days with a 20x Air NA0.75 PlanApochromat objective or a 10x Air NA0.25 Achromat objective.
To automatically stitch multiple stage positions and merge both green and red channels, we saved raw data as Metamorph stk/nd
ﬁles. We wrote speciﬁc Macros: vaquiea/VisiView_Stack-Assembler v1.0 (can be found at https://zenodo.org/record/844628) for Fiji
(ImageJ 1.5.1n, on Ubuntu Linux 64): the ﬁrst Macro (merge_stacks.py) is to merge green and red channels, and the second one
(rgb_converter.py) is to convert all data in RGBmode and adjust brightness and contrast using deﬁned minimal and maximal values.
Subsequently, tiles of all stage positions are stitched using Image Composite Editor (version 2.0.3.0 for Windows 7).
For 2D movies reconstruction, we stitched stage positions using three different methods on Fiji software (Preibisch et al., 2009)
(Ubuntu Linux 64): as ﬁrst option we ran the ND ﬁle (Multi series ﬁle) on the Stitching > Grid/Collection stitching Fiji Plugin. In case
this failed, we employed a different method as second option: we used the ND ﬁle to open in Fiji each stage position (containing chan-
nels and time-lapse data) andwe saved them in a separate folder as TIFF ﬁles and renamed them in the order of assembly as ‘‘tile_1,’’
‘‘tile_2,’’ ‘‘tile_3’’. We then ran this folder on the Stitching > Grid/Collection stitching Fiji Plugin (Type, Order and Grid size chosen
according to dataset; File names for tiles: tile_{i}.tif; First ﬁle index i: 1). In case this also failed, we used a third option: we proceeded
as for the second option until renaming the ﬁles as ‘‘tile_1,’’ ‘‘tile_2,’’ ‘‘tile_3’’.We then stitched sequentially tile_1 with tile_2, then
the output ﬁle with tile_3, etc., by using the Fiji Plugin stitching > pairwise stitching.
For 3D imaging, we also used theCSU-W1 spinning diskmicroscope to acquire confocal optical sections of 0.2 to 0.4 mm thickness
(between 30 and 70 stacks) at 4 or 20 min intervals on 1 to 3 stage positions during 8 to 24 h with a 40x Water NA1.25 Apochromat
objective. We saved raw data (multi-dimensional x, y, z) as STK ﬁles and Metadata as ND ﬁles. We wrote speciﬁc Macros: vaquiea/
VisiView_Stack-Assembler v1.0 (https://zenodo.org/record/844628) for Fiji to run the following workﬂow: ﬁrst, wemerged both green
and red channels (Macro: merge_stack.py) to create a multi-color hyperstack, second we stitched stage positions together to obtain
one spatially continuous volume (Macro: stick_x-y-stacks.py) and third we assembled the time-points (Macro: time_concatena-
tion.py). In the last step, we used the created hyperstack (having x, y, z spatial dimensions and color and time dimensions) to recon-
struct 3D surface rendering using Imaris on a Windows 7 machine with Intel Core i7 and 64 GB memory.
Generation of lentiviruses
For efﬁcient delivery of cDNA or shRNA in neurons, SCs and OLs, we used lentiviral vectors, which have also the advantage of
inducing minimal cell toxicity and mild expression.
Highly concentrated lentiviral particles were produced as previously described (Br€ugger et al., 2015). Constructs used to produce
lentiviruses: packaging constructs pLP1, pLP2 and pLP/VSVG (Invitrogen), pLV-LSyn-RFP (Nathanson et al., 2009, Addgene
construct#22909), pLentiLox 3.7 (ATCC), Lifeact-GFP (kind gift from Dr. Olivier Pertz, University of Bern, Switzerland), Lenti-ORF
clone of FLT1 (mGFP-tagged)-Human fms-related tyrosine kinase 1 (Origene), PlGF shRNA (Sigma, mission shRNA, cat. # SHCLNG,
TRCN0000065844) or a Control shRNA (Sigma, PLK0.1).
Laser axotomy
To produce precise and high-speed axonal lesions, we used a Visitron VisiScope CSU-W1 inverted spinning disk confocal micro-
scope (Nikon Ti-E) equipped with a motorized stage, a laser ablation module (MICROSHIP laser 355 nm passively Q-switched for
average power of 16mW, delivering 2-kWpeak power at repetition rates of 21 kHz) connected to a VisiFRAP-DC scanner, a hardware
autofocus (Perfect Focus), a small environmental sample chamber for temperature, CO2 and humidity control, a home-made insert
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(external dimensions of L: 76.6 mm, H: 3.1 mm,W: 26mm, upper opening of L: 50 mm, H: 0.7 mm,W: 23.8 mm, and lower opening of
L: 39.6 mm, H: 2.4 mm,W: 20.6 mm) for our microﬂuidic devices, a Scientiﬁc Grade 4.2 sCMOS camera, a multiband ﬁlterset for 405/
488/561 nm with single emission ﬁlter and a brightﬁeld bypass.
Laser axotomy was conducted with a 40x Water NA1.25 Apochromat objective after calibration in the FRAP dialog on the PDMS
surface devoid of cells (light intensity decreased to zero). A thin rectangular ROI was drawn spanning the width of the microgroove or
of a single axon.
Immunoﬂuorescence
To visualize the expression of speciﬁc proteins and label different cell types, we used immunoﬂuorescence. For immunoﬂuorescence
in microﬂuidic chambers, cells were ﬁxed twice for 15 min with 4% paraformaldehyde (PFA, Sigma) at room temperature (RT), and
washed twice for 15 min with PBS. Cells were subsequently blocked for 1 h with blocking buffer (0.3% Triton X-100/ 10% Goat
serum/ PBS), and then incubated for 2 days at 4C with primary antibodies in blocking buffer. Cells were then washed three times
for 30 min with blocking buffer and incubated for 3 h in the dark with secondary antibodies in blocking buffer. After three washes
of 30 min with blocking buffer, cells were incubated with DAPI for 30 min, washed again for 30 min and stored in PBS. For PlGF
and VEGFR1 immunoﬂuorescence, the entire above protocol was conducted in non-permeabilizing conditions in the absence of
Triton. For F-actin-Neuroﬁlament co-labeling, we ﬁrst carried out Neuroﬁlament immunoﬂuorescence, and then we incubated the
chambers for 2 h at RT with 1X Phalloidin-iFluor 488 Reagent – CytoPainter (Abcam, cat. #ab176753) diluted in PBS containing
1% BSA. In some cases, the chambers were incubated for 2 h at RT with Rhodamine Phalloidin (ThermoFisher, Cat#R415). The
chambers were then washed in PBS and incubated with DAPI.
Mouse sciatic nerves were ﬁxed in situ with 4% PFA (Sigma) for 15 min, embedded in O.C.T. Compound (VWR chemicals), and
frozen at80C.We used 5-mmcryosections for VEGFR1-F4/80, phospho-VEGFR1-F4/80 and PlGF-MBP co-immunoﬂuorescence,
and 60-mm or 5-mm cryosections for Neuroﬁlament and GAP43 immunoﬂuorescence with or without F-actin labeling. For phospho-
VEGFR1-F4/80, cryosections were blocked for 30 min at RT in blocking buffer (see above) and incubated overnight at 4C with
primary antibodies diluted in blocking buffer. Sections were then washed 3 times in blocking buffer and secondary antibodies
were incubated for 1 h at RT in the dark. Then, sections were washed, incubated with DAPI for 5 min at RT, washed again and
mounted in Citiﬂuor (Agar Scientiﬁc). For VEGFR1-F4/80, the steps were the same, except for the blocking buffer that did not contain
any Triton. For PlGF-MBP co-immunoﬂuorescence, we ﬁrst proceeded to PlGF immunoﬂuorescence in non-permeabilizing condi-
tions without Triton, then we post-ﬁxed with 4% PFA for 15 min at RT, washed and then carried out MBP immunoﬂuorescence in
permeabilizing conditions.
Sixty-mm thick cryosections were permeabilized for 3 h in blocking buffer (0.3% Triton X-100/ 10% Goat serum/ PBS) and then
incubated for 2 days at 4Cwith the primary antibody diluted in blocking buffer. After 3 washes of 5 min with blocking buffer, sections
were incubated with the secondary antibody for 3 h at RT in the dark in blocking buffer. Sections were then washed 3 times with
blocking buffer, incubated overnight with 1X Phalloidin-iFluor 488 Reagent – CytoPainter when applicable, washed 3 times with
blocking buffer, incubated with DAPI for 5 min, washed again with PBS and mounted in CitiFluor.
For immunoﬂuorescence on spinal cords, mice were deeply anesthetized with a lethal dose of pentobarbital and perfused with 4%
PFA after blood removal with heparin. Spinal cords were collected from the hemisection site to 7mmbelow or at an equivalent region
for unlesioned spinal cords, post-ﬁxed in 4% PFA for 2 h at RT, incubated in 20% sucrose overnight at 4C, embedded in O.C.T.
compound, and frozen at 80C. We used 5-mm cryosections. For VEGFR1/CC1 co-immunoﬂuorescence, sections were ﬁrst
submitted to antigen retrieval in citrate buffer (10mMcitrate buffer, 0.05%Tween20, pH6) for 2 h at 65Candwashed. Then, VEGFR1
immunoﬂuorescence was carried out in non-permeabilizing conditions, sections were then post-ﬁxed as above and thenMBP immu-
noﬂuorescence was carried out in permeabilizing conditions.
Primary antibodies: Neuroﬁlament (rabbit, 1:200, Millipore, cat. #AB1987), GAP43 (rabbit, 1:500, Abcam, cat. #ab75810), cJun
(rabbit, 1:200, Abcam, cat. #ab32137), MBP (rat, 1:50, Serotec, cat. #MCA409S), Sox10 (rabbit, 1:200, DCS Innovative Diagnos-
tik-Systeme, cat. #SI058C01), CC1 (mouse, 1:200, Millipore, cat. #OP80), F4/80 (rat, 1:400, Genetex, cat. #GTX26640), cleaved
Caspase 3 (rabbit, 1:300, Cell signaling, cat. #9661), VEGFR1 (rabbit, 1:200, Abcam, cat. #ab32152), PlGF (rabbit, 1:50, Abcam,
cat. #ab196666), phospho-VEGFR1 (Tyr1213) (rabbit, 1:200, Millipore, cat. #07-758), phospho(S204)-PAK1 (rabbit, 1:500,
Abcam, cat. #ab79503), Myosin heavy chain 1, fast, 2x (mouse, 1:200, Developmental Studies Hybridoma Bank, cat. #6H1 s).
All secondary antibodies were from Jackson ImmunoResearch and were multiple-labeling antibodies adsorbed against many
animal species immunoglobulins to avoid cross-reactivity. Photos were acquired either using the spinning disk system described
above or a Leica TCS SPE-II confocal microscope. Single optical sections or z series projections (stated in the ﬁgure legends) are
shown.
EdU assay
To quantify cell proliferation, we labeled cells with EdU. We used Click-iT Plus EdU Imaging Kit (Life Technologies). The EdU was
added to the microﬂuidic chambers for 1 h before ﬁxation, and the assay was conducted according to the instructions of the
manufacturer.
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RNA isolation
For RNaseq and qPCR analyses, we isolated RNAs from SCs cultured in our microﬂuidic models (content of chamber#2). We used
one microﬂuidic device per each n of 1dpl and unlesioned control (Ctrl). For 1dpl samples, axons of all microgrooves were cut by
laser. The content of chamber#2 of Ctrl and 1dpl was collected in RNase-free lysis buffer (PrepEaseRNA Spin Kit) and RNAs
were isolated using the manufacturer’s instructions (PrepEaseRNA Spin Kit, Affymetrix). To prevent contamination by chamber#1
content, a higher volume (PBS) was maintained in chamber#1 compared to chamber#2. RNAs were collected in RNase-free water
and were then processed through a second step for cleaning, using RNeasy MinElute Cleanup Kit (QIAGEN). Two hundred
nanogrammes RNAs in RNase-free water were sent for sequencing.
RNA sequencing and data analysis
To identify all regulated genes in SCs at 1dpl as compared to unlesioned conditions, we carried out RNaseq analyses. Each of the
total RNA extracted samples (see above ‘‘RNA isolation’’) was converted to an Illumina library with the TruSeq stranded mRNA kit,
following manufacturers recommendations. The sequencing was performed on a HiSeq2500, at multiplex level of 7, leading to ap-
prox. 21 mio SE reads of 100 bp per sample with the exception of one sample for which we got 97 mio reads for unknown reasons.
Data analysis: the raw reads were of excellent quality as judged by FastQC analysis (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/). No further ﬁltering or trimming was performed, the reads were remapped directly onto the Rattus norvegicus refer-
ence genome ver.6.0.82 (NCBI:GCA_000001895.4) and counted by gene using STAR 2.5.0b (Dobin et al., 2013). The counts were
concatenated into a tab delimited ﬁle and imported into RStudio for analysis with the DESeq2 package following standard operating
procedures (Love et al., 2014). We performed the differential expression (DE) analysis comparing 2 unlesioned control samples
versus 4 lesion samples leading to the identiﬁcation of 72 up- and 440 downregulated genes. Signiﬁcant genes are reported for
the Wald test with Benjamini-Hochberg multiple test correction (Benjamini and Hochberg, 1995) when the adjusted p value < 0.05
using an FDR of 10%. Gene ontology analyses were carried out using DAVID (https://david.ncifcrf.gov/), Uniprot (http://www.
uniprot.org/) and GeneCards (http://www.genecards.org/) databases and conﬁrmed in Pubmed, when necessary.
qRT-PCR
To conﬁrm the upregulation of Vegfr1 identiﬁed by RNaseq in SCs at 1dpl as compared to unlesioned conditions, we carried out
quantitative real-time PCR analyses using RNAs isolated from chamber#2 in unlesioned conditions and at 1dpl. We used an ABI
7000 Sequence Detection System (Applied Biosystems) and FastStart SYBRGreenMaster (Roche), according to themanufacturer’s
recommendations. A dissociation step was added to verify the speciﬁcity of the products formed. Primer sequences were as follows:
for rat Vegfr1, forward 50-GTGTCTATAGGTGCCGAGCC-30, reverse 50-GGGTGATCAGCTCCAGGTTT-30; for rat Gapdh, forward
50-GTATCCGTTGTGGATCTGACAT-30, reverse 50-GCCTGCTTCACCACCTTCTTGA-30.
ELISA
In the aim of identifying a VEGFR1 agonist that is released by neurons upon lesion, we carried out ELISA. To measure PlGF, VEGFA
and VEGFB release by neurons after lesion, we used puriﬁedDRGneurons cultured alone in ourmicroﬂuidic chambers. Before lesion,
we washed the chambers twice with Neurobasal medium and replaced the culture medium with Neurobasal (also in control cham-
bers not undergoing a lesion). To maximize the use of our chambers, we lesioned all axons in microgrooves and also the biggest
axons in chamber#1 and collected the supernatant of both chambers#1 and #2.We then pooled the content of 3microﬂuidic devices
(for each n), either at 1dpl or in unlesioned culture conditions. We centrifuged at 1000 x g for 15 min at 4C to pellet debris, and then
concentrated the supernatants 10 times using Wash Pierce Concentrators, cut off 10K MW (Thermo Scientiﬁc). We then adjusted
1dpl and unlesioned samples to the same volume with PBS and measured PlGF, VEGFA and VEGFB concentrations by ELISA (kits
#MBS7271125, MBS748119 and MBS269676, all from MyBioSource.com) according to the manufacturer’s instructions.
Toe pinch test
To evaluate whether ablation of VEGFR1 in SCs affects sensory function recovery after lesion, 3 to 4-month old Flt1 mutant and
control mice were subjected to a toe pinch test at 12, 15 and 20 dpsnl, as previously described (Br€ugger et al., 2017).
QUANTIFICATION AND STATISTICAL ANALYSIS
For each dataset, at least 3 independent samples were used, except for unlesioned control for SC RNA sequencing analysis (n = 2).
P values were calculated using two-tailed (black asterisks in the ﬁgures) or one-tailed (gray asterisks in the ﬁgures) paired or unpaired
Student’s t tests. All bar graphs with error bars represent the mean ± SEM. The difference between two groups was deﬁned as sta-
tistically signiﬁcant for the following p values: * < 0.05, ** < 0.01, *** < 0.001. The statistical details of experiments can be found in the
ﬁgure legends. The RNaseq analysis was carried out by differential expression (DE) analysis comparing 2 unlesioned control samples
versus 4 lesion samples. Signiﬁcant genes are reported for theWald test with Benjamini-Hochbergmultiple test correction (Benjamini
and Hochberg, 1995) when the adjusted p value < 0.05 using an FDR of 10%. For datasets obtained using animals or their tissues,
three to nine animals were used per group and tissues of each animal were processed independently. No randomization method was
used, but experimenters were blinded to the experimental group and received only the animal number given at birth by the animal
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caretaker. As control vehicle mice, we used littermate mice of the same sex. For datasets obtained using cells, three to seven
independent experiments were conducted and analyzed. For animal experiments, sample size was determined by the minimal
number of animals required to obtain statistically signiﬁcant results. No animal was excluded from the analysis. For the RNaseq, three
unlesioned control samples were collected but the RNA of one of them was of insufﬁcient quality and was thus excluded from the
analysis.
DATA AND SOFTWARE AVAILABILITY
All data are available from the corresponding author upon request. The accession number for the raw RNaseq data reported in this
paper is ENA: PRJEB32448. In addition, individual sample, experiment and run accession numbers for each sample are available in
Table S1, Tab C.
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